ArticleJACC. Clinical electrophysiology2025

Atrial Fibrillation in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Real-World Incidence, Management, and Outcomes.

Thomas A Boyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.